Upgrade to SI Premium - Free Trial

Form 3 PolyPid Ltd. For: Mar 18 Filed by: Akselbrad Dikla Czaczkes

March 18, 2026 4:02 PM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Akselbrad Dikla Czaczkes
(Last) (First) (Middle)
C/O POLYPID LTD.
18 HASIVIM STREET
(Street)
PETACH TIKVA 495376
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026 		3. Issuer Name and Ticker or Trading Symbol
PolyPid Ltd. [ PYPD ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 934
D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (right to buy) 07/05/2016 04/05/2026 Ordinary Shares 279 (1) 92.89 D
Stock option (right to buy) 08/25/2017 08/24/2026 Ordinary Shares 228 (2) 92.89 D
Stock option (right to buy) 03/21/2017 12/21/2026 Ordinary Shares 1,713 (3) 117.99 D
Stock option (right to buy) 08/08/2023 05/05/2033 Ordinary Shares 2,833 (4) 23.07 D
Stock option (right to buy) 10/01/2019 06/11/2030 Ordinary Shares 3,187 (5) 23.07 D
Stock option (right to buy) 08/09/2022 08/09/2032 Ordinary Shares 1,827 (6) 23.07 D
Stock option (right to buy) 07/01/2023 05/03/2032 Ordinary Shares 3,333 (7) 23.07 D
Stock option (right to buy) 08/07/2024 10/09/2033 Ordinary Shares 30,486 (8) 11.01 D
Stock option (right to buy) 08/06/2024 07/02/2034 Ordinary Shares 198,900 (9) 4.64 D
Stock option (right to buy) 06/09/2025 07/02/2034 Ordinary Shares 132,600 (10) 4.64 D
Stock option (right to buy) 08/12/2025 06/25/2035 Ordinary Shares 120,000 (11) 2.67 D
Stock option (right to buy) 06/09/2025 06/25/2035 Ordinary Shares 80,000 (12) 2.67 D
Explanation of Responses:
1. The options were granted on April 5, 2016 and fully vested as of April 5, 2019.
2. The options were granted on August 24, 2016 and fully vested as of August 24, 2019.
3. The options were granted on December 21, 2016 and fully vested as of December 21, 2019.
4. The options were granted on May 5, 2023 and vest on a quarterly basis until May 5, 2027.
5. The options were granted on June 11, 2020 and fully vested as of July 1, 2022.
6. The options were granted on August 9, 2021 and vest on a quarterly basis beginning August 9, 2022 until August 9, 2025.
7. The options were granted on May 3, 2022 and fully vested as of April 1, 2025.
8. The options were granted on October 9, 2023 and vest on a quarterly basis beginning August 7, 2024 until August 7, 2027.
9. The options were granted on July 2, 2024 and vest on a quarterly basis until May 6, 2028.
10. The options were granted on July 2, 2024 and vest on a quarterly basis until May 6, 2026.
11. The options were granted on June 25, 2025 and vest on a quarterly basis until May 12, 2029.
12. The options were granted on June 25, 2025 and vest on a quarterly basis until May 12, 2027.
/s/ Dikla Czaczkes Akselbrad 03/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings